Halted prematurely due to low enrollment

This study will assess the impact of lymphaticovenous microanastomosis in volume reduction of postmastectomy upper extremity lymphedema. We hypothesize that multiple lymphaticovenous micro-anastomosis in the distal arm will result in the reduction of volume and improvement in quality of life of patients with post-mastectomy lymphedema

Inclusion Criteria:

• Subject is 18-70 years of age
• Subject is Stage II-IV unilateral lymphedema

Exclusion Criteria:

• Subject is less than 6 months from completion of cancer treatment
• Subject has allergic reaction to the lymphatic contrast agent (Indocyanine Blue)
• Subject is medically unfit for the procedure
• Subject is unable to complete the follow-up visits
• Women with a positive urine pregnancy test are excluded from this study; women of childbearing potential (defined as those who have not undergone a hysterectomy or who have not been postmenopausal for at least 24 consecutive months) must agree to refrain from breast feeding and practice adequate contraception as specified in the informed consent. Adequate contraception consists of oral contraceptive, implantable contraceptives, injectable contraceptives, a double barrier method, or abstinence.
• Subject has bilateral lymphedema

6 months

Early termination leading to small numbers of subjects. Outcome measures not computed because data would not be statistically relevant.